Status: Not yet recruiting
Chronic Evaluation of Novel Pacemaker System
The primary study objective is to evaluate the feasibility, initial clinical safety and potential effectiveness of the Calyan Pacemaker system.
Participants needed: 10
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Calyan TechnologiesUpdated: Mar 18, 2026Locations: 1
Eligibility criteria
Age 18 or above [+3]
Patients with complete AV block or other pacemaker-dependent conditions [+24]